The simplified method for quantifying metabolic syndrome (siMS) score reflects an increased cardiometabolic burden: adiposity, hemodynamics, and HRV findings in young adults
Open Access
- 19 February 2026
- journal article
- research article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 25 (1) , 66
Abstract
Purpose: Metabolic Syndrome (MetS) increases cardiovascular disease risk, yet early identification of pre-MetS remains challenging. The Simple Method for Quantifying MetS (siMS) score offers potential for detecting cardiometabolic burden in younger and middle-aged, relatively healthy populations. Methods: We stratified 51 healthy adults (aged 18–60 years) into Low siMS (LMS, siMS < 2.085, n = 25) and High siMS (HMS, siMS ≥ 2.085, n = 26) groups based on the median siMS score and compared central hemodynamic parameters, heart rate variability (HRV), and microvascular function as independent predictors of cardiometabolic risk between these groups. Anthropometrics, body composition, hemodynamics (e.g., central blood pressure [BP], mean arterial pressure [MAP]), HRV (e.g., %R-R intervals > 50 msec, pNN50; high-frequency power), microvascular reactivity (near-infrared spectroscopy vascular occlusion test), blood glucose and lipid profiles, and dietary intake were assessed using established protocols. Results: The HMS group exhibited significantly higher body mass, body mass index (BMI), waist and hip circumferences, fat mass, visceral fat, central and peripheral BP, MAP, and augmentation index adjusted to 75 bpm (all p ≤ 0.004), alongside lower HRV metrics (pNN50, high-frequency power, low-frequency power, and total power, p ≤ 0.003), indicating increased cardiometabolic burden. No differences were observed in blood glucose, lipids, dietary intakes, or microvascular reactivity. Conclusion: These findings suggest that higher siMS scores reflect early cardiometabolic risk through adverse hemodynamic and autonomic profiles, even in the absence of overt MetS, metabolic abnormalities, or detectable microvascular dysfunction. The siMS score may serve as a proactive tool for identifying at-risk individuals, supporting targeted interventions to mitigate long-term cardiometabolic risk.Keywords
Funding Information
- Plexus Worldwide LLC (2209-1044)
- Plexus Worldwide LLC (2209-1044)
- Plexus Worldwide LLC (2209-1044)
- American Heart Association (24AIREA1247045)
This publication has 37 references indexed in Scilit:
- Long-term association of ultra-short heart rate variability with cardiovascular eventsScientific Reports, 2023
- Does sex influence near-infrared spectroscopy-derived indicators of microvascular reactivity and the response to acute dietary capsaicinMicrovascular Research, 2022
- Clusters of risk factors in metabolic syndrome and their influence on central blood pressure in a global studyScientific Reports, 2022
- Metabolic syndrome and peripheral neuropathyMuscle & Nerve, 2020
- Cardiovascular risk and heart rate variability in young adults with type 2 diabetes and arterial stiffness: The SEARCH for Diabetes in Youth StudyJournal of Diabetes and its Complications, 2020
- Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016JAMA, 2020
- Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative ReviewDiabetes Therapy, 2019
- Near-infrared spectroscopy assessment of microvasculature detects difference in lower limb vascular responsiveness in obese compared to lean individualsMicrovascular Research, 2018
- Derivation and Validation of Diagnostic Thresholds for Central Blood Pressure Measurements Based on Long-Term Cardiovascular RisksJACC, 2013
- Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose–response meta-regressionEP Europace, 2013